Intrinsiqq
Astrana Health Inc. logo

Astrana Health Inc. Financials

ASTH

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 25 available years
Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
94:1 split
DEC 2022
SEP 2022
Revenues
Revenue$3,844$3,182$2,035$1,387$1,144–
Cost of Revenue$3,505$2,886$1,791$1,189$962–
Gross Profit$339$296$243$197$182–
General & Administrative$239$217$154$113$78–
Total Operating Expenses$3,744$3,103$1,945$1,302$1,040–
Operating Income$100$79$89$85$104–
Non-Operating
Net Interest Expense-$50-$38-$19-$2-$6–
Other Non-Operating Income (Expense)$10-$1$10$7-$12–
EBT (Earnings Before Tax)$60$40$81$90$87–
Income Tax Expense$21$16$31$32$41–
Minority Interest-$1$2$7-$3$1–
Net Income
Net Income$41$22$43$61$45–
Per Share Data
Revenue Per Share$77.23$64.45$42.41$29.54$25.09–
EPS (Basic)$0.83$0.46$0.91$1.30$1.00–
EPS (Diluted)$0.82$0.46$0.90$1.29$0.99–
Weighted Avg Shares (Basic)49.1M49.1M47.6M46.6M45.0M–
Weighted Avg Shares (Diluted)49.8M49.4M48.0M46.9M45.6M–
Shares Outstanding49.8M49.4M48.0M46.9M45.6M–
Dividends Per Share$0.04$0.16$0.08$1.32$0.31–

Astrana Health (ASTH) financials: revenue, profit and margins

Astrana Health (ASTH) generated about $3.8 billion in revenue and $41 million in net income (a 1.1% net margin) over the trailing twelve months, growing at roughly 35.9% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Astrana Health's (ASTH) revenue?+

Astrana Health generated about $3.8 billion in revenue over the trailing twelve months. Revenue has grown at roughly 35.9% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Astrana Health profitable?+

Yes, Astrana Health reported about $41 million in net income over the trailing twelve months, a net profit margin of roughly 1.1%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Astrana Health's profit margins?+

Astrana Health runs a gross margin of about 8.8%, an operating margin of about 2.6%, a net margin of about 1.1%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Astrana Health growing?+

Astrana Health's revenue has compounded at roughly 35.9% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ASTH's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 3 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Services-Management Consulting Services · Pick stocks to compare with ASTH

CompareIntrinsic value
FCNFti Consulting Inc.
$198.32+2.41%66
GGenpact Ltd.
$40.78+1.39%76
ICFIICF International Inc.
$96.91-0.76%57
HURNHuron Consulting Group Inc.
$173.02-12.69%78
MEGOnterris, Inc.
$16.13+2.80%54
RMRRMR Group Inc.
$16.70+0.54%42
EXPOExponent Inc.
$87.43+1.70%59
BWMNBowman Consulting Group Ltd.
$42.93-0.07%54

Held by ETFs

ASTH is in 62 US ETFs. The largest of them, with ASTH's weight in each:

Spot a number that looks wrong? Check it in ASTH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ASTH

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.